Dextrins as potential carriers for drug targeting: tailored rates of dextrin degradation by introduction of pendant groups
- 1 November 2001
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 230 (1-2), 57-66
- https://doi.org/10.1016/s0378-5173(01)00859-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Dextrins as Carriers for Drug Targeting: Reproducible Succinoylation as a Means to Introduce Pendant GroupsJournal of Bioactive and Compatible Polymers, 2001
- Polymer conjugates for tumour targeting and intracytoplasmic delivery. The EPR effect as a common gateway?Pharmaceutical Science & Technology Today, 1999
- Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNAInternational Journal of Pharmaceutics, 1999
- Icodextrin Provides Long Dwell Peritoneal Dialysis and Maintenance of Intraperitoneal VolumeArtificial Organs, 1998
- Pharmacokinetic evaluation of polymeric carriersAdvanced Drug Delivery Reviews, 1996
- Synthesis of Carboxymethylpullulan-Peptide-Doxorubicin Conjugates and Their Properties.CHEMICAL & PHARMACEUTICAL BULLETIN, 1995
- Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrierEuropean Journal Of Cancer, 1995
- Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD)Investigational New Drugs, 1993
- The clinical efficacy of poly(ethylene glycol)-modified proteinsJournal of Controlled Release, 1990
- Effect of the Chemical Modification of Dextran on the Degradation by DextranaseJournal of Bioactive and Compatible Polymers, 1990